News

Find News

Filter articles

Showing 1 to 10 of 2503 results

CMA accuses 4 pharma companies of anti-competitive conduct

UK24-05-2019

Four pharmaceutical companies allegedly agreed not to compete for the supply of an anti-nausea tablet to the National Health Service, according to objections filed by the UK Competition and Markets Authority.

‘Considerable increase’ in pay-for-delay settlements: FTC report

US24-05-2019

The number of ‘pay-for-delay’ patent settlements reached in fiscal year 2016 represented a “considerable increase” from the previous year, according to a Federal Trade Commission report released yesterday, May 23, though there has been a considerable reduction in the most problematic settlements since 2013.

Eli Lilly releases generic insulin injection

US23-05-2019

Eli Lilly has released a generic insulin injection at half of the list price of its identical branded medicine to the US market.

City of Baltimore accuses Janssen of delaying generics

US23-05-2019

Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is being sued for “unlawfully” delaying generic competition to Zytiga, its branded cancer medication.

Merck boosts oncology pipeline with $1bn deal

US22-05-2019

Merck has announced plans to acquire Peloton Therapeutics, a clinical-stage biopharmaceutical company, in a $1.05 billion bid to boost its oncology pipeline.

Alphabet's Verily in digital research alliance with Pfizer and others

22-05-2019

Verily, which is a subsidiary of Google’s parent company Alphabet, yesterday announced that it had partnered with Novartis, Otsuka, Pfizer, and Sanofi in efforts to develop digitally-innovative clinical research programmes.

Genentech enters agreement to develop autoimmune therapies

US21-05-2019

US-based biopharmaceutical company Parvus Therapeutics has entered into a collaboration and licensing agreement with Genentech, a subsidiary of Roche.

Gilead claims US government PrEP patents are invalid

US20-05-2019

Gilead’s CEO has told a US House of Representatives committee that three Centers for Disease Control HIV prevention patents are invalid.

Delhi High Court issues landmark nutraceuticals judgment

India20-05-2019

The High Court of Delhi has ruled that the test for passing off of so-called nutraceuticals should be the same as that for pharmaceuticals.

Federal Circuit invalidates Nuvo’s Vimovo patents

US17-05-2019

The US Court of Appeals for the Federal Circuit has delivered a blow to Nuvo Pharmaceuticals by reversing a decision which had upheld the validity of the Canadian company’s pain relief drug Vimovo.

Showing 1 to 10 of 2503 results

LSIPR